| First penicillin-binding protein occupancy patterns for 15 β-lactams and β-lactamase inhibitors in Mycobacterium abscessus ARM Sayed, NR Shah, KB Basso, M Kamat, Y Jiao, B Moya, DS Sutaria, ... Antimicrobial agents and chemotherapy 65 (1), 10.1128/aac. 01956-20, 2020 | 17 | 2020 |
| High-dose metformin may increase the concentration of atorvastatin in the liver by inhibition of multidrug resistance–associated protein 2 E Shin, N Shin, JH Oh, YJ Lee Journal of pharmaceutical sciences 106 (4), 961-967, 2017 | 16 | 2017 |
| Combating multidrug‐resistant bacteria by integrating a novel target site penetration and receptor binding assay platform into translational modeling Y Lang, NR Shah, X Tao, SM Reeve, J Zhou, B Moya, ARM Sayed, ... Clinical Pharmacology & Therapeutics 109 (4), 1000-1020, 2021 | 12 | 2021 |
| Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947–2019 JL Kennedy, JB Bulitta, K Chatham-Stephens, MK Person, R Cook, ... Clinical infectious diseases 75 (Supplement_3), S379-S391, 2022 | 7 | 2022 |
| Comparable bioavailability and disposition of pefloxacin in patients with cystic fibrosis and healthy volunteers assessed via population pharmacokinetics JB Bulitta, Y Jiao, CB Landersdorfer, DS Sutaria, X Tao, E Shin, R Höhl, ... Pharmaceutics 11 (7), 323, 2019 | 4 | 2019 |
| Deproteinization with ZnSO4–Ba(OH)2 reduces the photodegradation of montelukast during plasma sample preparation for HPLC analysis E Shin, JH Oh, JH Lee, YJ Lee Journal of Liquid Chromatography & Related Technologies 39 (11), 520-525, 2016 | 3 | 2016 |
| Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics E Shin, Y Zhang, J Zhou, Y Lang, ARM Sayed, C Werkman, Y Jiao, ... Antimicrobial Agents and Chemotherapy, e01393-23, 2024 | 2 | 2024 |
| Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula JB Bulitta, E Shin, PJ Bergen, Y Lang, A Forrest, BT Tsuji, B Moya, J Li, ... Journal of Pharmaceutical Sciences 113 (1), 202-213, 2024 | 1 | 2024 |
| Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis M Nantongo, DC Nguyen, CR Bethel, MA Taracila, Q Li, KM Dousa, ... ACS Infectious Diseases, 2024 | | 2024 |
| Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug … J Zhou, Y Qian, Y Lang, Y Zhang, X Tao, B Moya, ARM Sayed, ... Antimicrobial Agents and Chemotherapy, e01399-23, 2024 | | 2024 |
| 2806. The Mechanism of β-Lactam Antibiotic Action: Structural Analysis of Mycobacterium abscessus l,d-Transpeptidases, d,d-Carboxypeptidase and penicillin … E Shin, M Nantongo, KM Dousa, CR Bethel, MA Taracila, BN Kreiswirth, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2417, 2023 | | 2023 |
| 2565. In vitro synergistic bacterial killing of imipenem and ceftaroline against Mycobacterium abscessus; a static concentration time-kill analysis E Shin, M Nantongo, SM Holland, BN Kreiswirth, KM Dousa, RA bonomo Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2182, 2023 | | 2023 |
| Synergistic Effects of Sulopenem in Combination with Cefuroxime or Durlobactam against Mycobacterium abscessus KM Dousa, E Shin, SG Kurz, M Plummer, M Nantongo, CR Bethel, ... bioRxiv, 2023.12. 15.571879, 2023 | | 2023 |
